HomePARKHOSPS › Filing
🔔 Get instant alerts when PARKHOSPS files quarterly results on BSE Start free trial →

Investor Presentation Q1 FY''27

Filed: 03 Aug 2026, 09:49 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 revenue grew 19% YoY to ₹4,757 mn; EBITDA rose 20% YoY to ₹1,261 mn with 26.5% margin - Net profit increased 35% YoY to ₹886 mn; net profit margin expanded 220 bps YoY to 18.6% - Total bed capacity up 32% YoY to 3,960 beds; 46% capacity addition planned in calendar 2026 - Acquisitions include The Medicity Hospital Rudrapur (330 beds) and Mehar Hospital Zirakpur (150 beds) - Capacity expected to reach 4,740 beds by FY27 end and 5,740 beds by March 2028 - Growth funded mainly through internal accruals and IPO proceeds, with no material fresh debt - Focus on integrating acquisitions, improving utilization, and sustaining profitability - Strong balance sheet with negative net debt and ₹2,998 mn in fixed deposits - Expansion driven by cluster strategy, super-speciality capabilities, and high-acuity care
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PARKHOSPS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PARKHOSPS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Park Medi World Limited

Important. The summary above is generated automatically from Park Medi World Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.